| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Revenue | $782.3M | -23.6% |
| Cost of Revenue | $321.7M | -15.7% |
| Gross Profit | $460.6M | -28.3% |
| R&D Expense | $337.7M | +1.6% |
| SG&A Expense | $147.0M | -23.0% |
| Operating Income | -$24.2M | -120.3% |
| Interest Expense | $5.6M | -17.4% |
| Pre-tax Income | -$26.6M | -120.5% |
| Income Tax | $7.9M |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $227.5M | -54.5% |
| Short-term Investments | $211.7M | -69.4% |
| Accounts Receivable | $29.3M | -59.0% |
| Inventory | $194.3M | +93.5% |
| Current Assets | $737.9M | -49.5% |
| Total Assets | $1.44B | -33.5% |
| Current Liabilities | $163.6M | -12.0% |
| Line Item | 2023-12-30 | Y/Y |
|---|---|---|
| Capital Expenditures | $22.3M | -16.0% |
| Financing Cash Flow | -$711.9M | +19.7% |
| -79.3% |
| Net Income | -$34.5M | -137.8% |
| EPS (Basic) | -$1.09 | -141.8% |
| EPS (Diluted) | -$1.09 | -142.9% |
| Total Liabilities |
| $234.4M |
| -69.3% |
| Stockholders' Equity | $1.21B | -14.0% |